EcoDrugPlus

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSLOCG00000016099
Gene Symbol: LOC102690375
3 Cross references
202 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSLOCG00000008713
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSLOCG00000012190
Gene Symbol: AOC2
1 Cross references
411 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSLOCG00000007972
Gene Symbol: AMY1C
4 Cross references
213 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSLOCG00000010764
Gene Symbol: APPB
1 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSLOCG00000014680
Gene Symbol: AR
3 Cross references
277 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSLOCG00000017406
Gene Symbol: AGTR1
3 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSLOCG00000017471
Gene Symbol: AGTR2
3 Cross references
191 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSLOCG00000006674
Gene Symbol: APH1A
2 Cross references
130 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSLOCG00000015516
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSLOCG00000014089
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSLOCG00000009354
Gene Symbol: ALOX5
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).